Wächtershäuser A - Search Results

1

Expression of 5-lipoxygenase by human colorectal carcinoma Caco-2 cells during butyrate-induced cell differentiation.

Wächtershäuser A, Steinhilber D, Loitsch SM, Stein J. Wächtershäuser A, et al. Biochem Biophys Res Commun. 2000 Feb 24;268(3):778-83. doi: 10.1006/bbrc.2000.2213. Biochem Biophys Res Commun. 2000. PMID: 10679282

2

Butyrate impairs intestinal tumor cell-induced angiogenesis by inhibiting HIF-1alpha nuclear translocation.

Zgouras D, Wächtershäuser A, Frings D, Stein J. Zgouras D, et al. Among authors: wachtershauser a. Biochem Biophys Res Commun. 2003 Jan 24;300(4):832-8. doi: 10.1016/s0006-291x(02)02916-9. Biochem Biophys Res Commun. 2003. PMID: 12559948

3

PPAR-gamma is selectively upregulated in Caco-2 cells by butyrate.

Wächtershäuser A, Loitsch SM, Stein J. Wächtershäuser A, et al. Biochem Biophys Res Commun. 2000 Jun 7;272(2):380-5. doi: 10.1006/bbrc.2000.2793. Biochem Biophys Res Commun. 2000. PMID: 10833422

4

Butyrate-induced differentiation of Caco-2 cells occurs independently from p27.

Wächtershäuser A, Stein J. Wächtershäuser A, et al. Biochem Biophys Res Commun. 2001 Feb 23;281(2):295-9. doi: 10.1006/bbrc.2001.4346. Biochem Biophys Res Commun. 2001. PMID: 11181044

5

1,25-Dihydroxycholecalciferol enhances butyrate-induced p21(Waf1/Cip1) expression.

Gaschott T, Wächtershäuser A, Steinhilber D, Stein J. Gaschott T, et al. Among authors: wachtershauser a. Biochem Biophys Res Commun. 2001 Apr 27;283(1):80-5. doi: 10.1006/bbrc.2001.4756. Biochem Biophys Res Commun. 2001. PMID: 11322770

6

HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2.

Wächtershäuser A, Akoglu B, Stein J. Wächtershäuser A, et al. Carcinogenesis. 2001 Jul;22(7):1061-7. doi: 10.1093/carcin/22.7.1061. Carcinogenesis. 2001. PMID: 11408350

7

Activation of PPARgamma is not involved in butyrate-induced epithelial cell differentiation.

Ulrich S, Wächtershäuser A, Loitsch S, von Knethen A, Brüne B, Stein J. Ulrich S, et al. Among authors: wachtershauser a. Exp Cell Res. 2005 Oct 15;310(1):196-204. doi: 10.1016/j.yexcr.2005.07.007. Exp Cell Res. 2005. PMID: 16112107

8

[Nonsteroidal anti-rheumatic drugs and colon carcinoma: COX versus PPAR].

Wächtershäuser A, Stein J. Wächtershäuser A, et al. Z Gastroenterol. 1999 Mar;37(3):257-61. Z Gastroenterol. 1999. PMID: 10234800 German. No abstract available.

9

Rationale for the luminal provision of butyrate in intestinal diseases.

Wächtershäuser A, Stein J. Wächtershäuser A, et al. Eur J Nutr. 2000 Aug;39(4):164-71. doi: 10.1007/s003940070020. Eur J Nutr. 2000. PMID: 11079736 Review.

10

[Interdisciplinary obesity treatment].

Wächtershäuser A, Stein J. Wächtershäuser A, et al. Pharm Unserer Zeit. 2006;35(6):506-10. doi: 10.1002/pauz.200600196. Pharm Unserer Zeit. 2006. PMID: 17137081 Review. German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters